PHS
CNC icon

PFM Health Sciences’s Centene CNC Stock Holding History

PFM Health Sciences’s Portfolio CNC Stock Details CNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.66M Buy
+88,200
New +$4.72M 0.49% 65

Other funds holding CNC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

PFM Health Sciences's CNC Position: Q2 2026 in Review

PFM Health Sciences reduced its Centene (CNC) stake by 5.5% in Q2 2026, selling an estimated $782K and leaving 248,867 shares worth $16M. The position accounts for 1.37% of the portfolio, ranked #23.

PFM Health Sciences first reported a position in CNC in Q3 2014 and has held it in 27 quarters since. The position peaked at $94.1M in Q2 2022. 1,004 funds tracked by Wall St. Rank hold CNC as of Q2 2026.

  • PFM Health Sciences held 248,867 shares of Centene worth $16M as of Q2 2026.
  • PFM Health Sciences sold 14,619 Centene shares in Q2 2026, an estimated $782K.
  • Centene made up 1.37% of PFM Health Sciences's portfolio in Q2 2026, its #23 holding.
  • PFM Health Sciences first reported a position in Centene in Q3 2014 and has held it in 27 quarters since.
  • PFM Health Sciences's Centene position peaked at $94.1M in Q2 2022.
  • 1,004 funds tracked by Wall St. Rank held Centene as of Q2 2026.

Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.